Cancer therapies for pets first, and their people next
Cancer impacts 6,000,000 dogs every year
We engineer living immune cells so they can fight cancer. It's called CAR-T cell therapy, and it's curative in humans with blood cancers. We're the first in the world to put dogs into remission with this therapy. Our work will revolutionize companion animal oncology while informing the next generation of CAR-T cells for humans. At LEAH Labs, we're helping cure cancer at both ends of the leash.
Currently funded by:
Investors:
Y Combinator, AgStartup Engine, FIN Capital,
Southeast Minnesota Capital,
Wefunder, various angel investors
Grants:
NSF SBIR, NIH SBIR, LaunchMN,
Regenerative Medicine Minnesota